Director, Rare Disease Market Access Strategy

About This Role

The Director of Rare Disease Market Access Strategy will lead development and execution of MA&R strategy for Friedreich Ataxia (FA), including the development of payer messaging, pricing & contracting strategy, coordination across all other MA&R functions, and alignment with the Rare Disease Franchise. This role will report to the Head of Rare Disease Access Strategy within the US Market Access & Reimbursement and lead a rare disease access strategy team in optimizing access for Friedreich Ataxia (FA).

• Develop and execute comprehensive market access strategies to support the FA brands across commercial and government payer segments.
• Lead cross-functional planning and execution across all MA&R functions (including Payer Insights, Trade & Distribution, Patient Access, and National & Regional Account Teams) to ensure alignment with approved strategies.
• Ensure coordination and alignment with the Rare Disease Franchise, including on overall strategy as well as internal and external messaging.
• Deliver impactful value propositions, messaging, and promotional materials (both branded and unbranded) tailored to key customer segments (e.g., plans, PBMs, GPOS, IDNs).
• Champion pull‑through activities to ensure access optimization.
• Partner with Medical, HEOR, Global V&A to support evidence generation to support access strategy.
• Define and drive the contracting strategy in collaboration with Brand, legal, and finance to align with market dynamics and brand goals.
• Develop pricing and innovative contracting strategies (e.g., value‑based contracts).
• Work with cross‑functional teams to model scenario‑based business cases to support key contracting recommendations to senior leadership.
• Research, compile, analyze, and assess market landscape data/trends to develop customized solutions that maximize patient access.
• Support development of Free Drug and co‑pay support strategies.
• Support development of SP and SD strategies to optimize patient access.
• Execute and support training of MA&R RADs and NADs in alignment with approved strategies and materials.
• Lead initiatives to evaluate MA&R performance in support of the Rare Disease Franchise.
• Lead and support multiple cross functional teams in various projects as a market access expert (e.g., gross‑to‑net work streams, forecasting, long‑range planning, etc.).
• Support pipeline activities, including Biogen’s pipeline assets for rare disease.

You are a proactive team leader with strong communication and analytic skills with deep expertise in the US healthcare system.

• Bachelor’s degree required, MBA preferred.
• 10+ years of experience in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry.
• Ability to work cross‑functionally to develop payer messaging, contracting strategy, build business cases, and develop training/communication plans for field teams.
• Knowledge of standard Payer research methodologies, financial analyses, and gross‑to‑net dynamics.
• Excellent analytical, strategic thinking and critical thinking skills with the ability to translate data into strategy.
• Must be highly motivated with strong interpersonal and communications skills.
• Ability to develop and deliver clear, compelling presentations on complex pricing topics to senior‑level executive audience.
• Ability to handle multiple tasks and effectively prioritize to meet individual and team goals.
• Must be able to produce high quality, accurate work under time constraints.
• Ability to build and maintain strong cross‑functional and cross‑team ties to influence colleagues.
• Must have the ability to work effectively in a team environment.

Management

The base compensation range for this role is: $-$.

Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

Regular employees are eligible to receive both short term and long term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential…